New Delhi: Bharat Biotech on Wednesday said a study has demonstrated that booster dose of Covaxin has neutralising effect on the Omicron and Delta variants of COVID-19.
A study conducted at Emory University demonstrated that subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary two-dose series have witnessed neutralising of the SARS-CoV-2 Omicron and Delta variants, the vaccine major said in a statement.
Earlier studies had demonstrated the neutralising potential of Covaxin against other SARS-CoV-2 variants — Alpha, Beta, Delta, Zeta and Kappa, it added.
Also read: Labs pull out all stops to cope with Omicron rush of tests
Trending Stories
- Cloudburst in North Sikkim sparks alert across the state
- Arunachal: Granddaughter of Mahatma Gandhi visits Ziro
- Taylor Swift and the end of the Hollywood writers strike: A tale of two media narratives
- Former Congress MLA KT Rokhaw resigns, joins MNF ahead of elections
- Manipuri-English film promoting gender-neutral fashion to be screened in Mumbai
- Manipur: Delhi court prolongs NIA custody of accused for eight days
